OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Neurology is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
A real-world study on the utility of regular rituximab treatment for neuromyelitis optica spectrum disorder	154
Prevalence of infratentorial superficial siderosis in a large general population sample from the UK Biobank	110
The deltoid muscle and the pattern of paresis in ALS	108
Tau levels in platelets isolated from Huntington’s disease patients serve as a biomarker of disease severity	104
A role for the Epstein–Barr virus in multiple sclerosis aetiology?	94
Pallidal deep brain stimulation for patients with myoclonus-dystonia without SGCE mutations	94
Richard Caton (1842-1926)	93
CSF biomarkers of B-cell activation in multiple sclerosis: a clinical perspective	85
Long-term outcome after decompressive hemicraniectomy for malignant middle cerebral artery infarction	83
Microstructural characterization of multiple sclerosis lesion phenotypes using multiparametric longitudinal analysis	82
Neuromyelitis optica spectrum disorder with a familial Mediterranean fever gene E84K mutation	78
Tacrolimus-induced Parkinsonism	77
Explaining recovery from coma with multimodal neuroimaging	77
Interpretable deep learning survival predictions in sporadic Creutzfeldt–Jakob disease	68
Different patterns of acute saccadic response to levodopa in de novo Parkinson’s disease	63
Reversible cerebral vasoconstriction syndrome after intravenous iron substitution: a case report	61
Epileptic disorders in Becker and Duchenne muscular dystrophies: a systematic review and meta-analysis	60
Phenotype-driven reanalysis reveals five novel pathogenic variants in 40 exome-negative families with Charcot–Marie–Tooth Disease	59
Neurological manifestation of HEV infection: still a rare disease entity?	59
Brain 18F-FDG PET findings and sequential vestibular testing in SCA27B: a case report	56
Correction to: Synergistic effects of vagus nerve stimulation and antiseizure medication	55
The DeMyers: Marian (1922–2012) and William (1924–2008)	53
Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod	53
Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study	52
Radiation-induced intracranial vasculitis on high-resolution vessel wall MRI	51

Brain network topology and future development of freezing of gait in Parkinson’s disease: a longitudinal study	50
Sensory neuropathy due to RFC1 in a patient with ALS: more than a coincidence?	48
Does visuospatial motion perception correlate with coexisting movement disorders in Parkinson’s disease?	48
Correction to: Late‑onset Huntington’s disease associated with CAG repeat lengths of 30 and 31	48
SARA captures disparate progression and responsiveness in spinocerebellar ataxias	47
Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies	46
Historical and current issues in HIV encephalitis, and the role of neuropathology in HIV disease: a pathological perspective	46
Correction to: Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national study	46
Neural correlates of dual-task walking in people with central neurological disorders: a systematic review	45
Assessment of cognitive function, structural brain changes and fatigue 6 months after treatment of neuroborreliosis	45
Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study	45
Analysis of C9orf72 repeat length in progressive supranuclear palsy, corticobasal syndrome, corticobasal degeneration, and atypical parkinsonism	44
Natalizumab-induced pneumonitis	44
Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy	44
A decision aid is not the quick fix for improving shared decision-making in advanced Parkinson’s disease: results of a mixed methods feasibility study	44
Exploring epigenetic modifications as potential biomarkers and therapeutic targets in amyotrophic lateral sclerosis	44
International survey on the implementation of the European and American guidelines on disorders of consciousness	44
TS-HDS autoantibody: clinical characterization and utility from real-world tertiary care center experience	43